Pancreatic Stem Cells
Can Be A Cure For Diabetes
posted September
08, 2004
Toronto University scientists have
said that stem cells can be a cure for diabetes, thereby eradicating the need
for replacing insulin.
The discovery could help scientists develop better treatments for diabetics and
basically change the way they think about cell development.
The lead scientists of the study have identified individual cells in the adult
mouse pancreas that are capable of making insulin-producing "beta cells." These
beta cells make up the tissues in the organ that release insulin and help
regulate the body's blood sugar levels.
If further research proves that the researchers did indeed identify stem cells,
the discovery could help scientists develop better treatments for diabetics and
basically change the way they think about cell development.
"We are refraining from actually saying that they are bona fide stem cells
because in order to actually earn that label, they must be characterized a bit
further," says Simon Smukler, who conducted the study at the University of
Toronto with fellow PhD student Raewyn Seaberg and supervisor Prof. Derek van
der Kooy.
Smukler says the cells identified by the study, to be published Monday in the
online edition of Nature Biotechnology, have exhibited one of the two major
properties of stem cells: they generate varied cell types. In this case, the
cells generated insulin-producing beta cells and -to the researchers' surprise
-neurons, those cells which help the brain and nervous system function.
The existing "dogma" about cell development says there is a distinct group of
cells destined to make the brain and another to make the pancreas, Smukler says.
This discovery could change all that, he adds, because it shows that a single
cell in the pancreas can make both beta cells and nerve cells.
"It was unexpected and intriguing, and kind of neat," he says. Smukler says he's
not sure why that happens, but it's possible that there could be previously
unnoticed cells in the body that make both types of cells.
True stem cells also renew themselves, which Smukler says has yet to be proven
in these "precursor" cells, although he's hoping to further the research.
Clinical studies based on the study are still a long way off, but he says the
finding could potentially affect the way diabetes is treated -particularly Type
1 diabetes, where the body doesn't have enough beta cells to produce insulin.
Finding donor tissue for pancreatic cell transplants in Type 1 cases is
complicated, he says. But the study could point to alternative -and plentiful
-sources of insulin-producing cells.
"The more we learn about the behaviour of these cells and the characteristics of
these cells, and the more we learn what signals trigger and effect their
behaviour ... then it raises the possibility of perhaps being able to manipulate
these cells and send them signals without actually removing them from the
tissue."
Source: Diabetes In Control.com:
Online edition
of Nature Biotechnology Aug 30,2004.
September 2004 News Article Index